top of page

Gunning Group recognized with Connaught Innovation Award!

Apr 8, 2022
1 min read

The Gunning Group has received a Connaught Innovation Award to support the development of HDAC2 inhibitors for the treatment of Duchenne Muscular Dystrophy (DMD)

Comments

Featured Posts

Congrats Murtaza on Publishing the Tetris-based approach to targeting HDAC8

Congrats Murtaza on Publishing the Tetris-based approach to targeting HDAC8

Congrats Murtaza on Publishing the Tetris-based approach to targeting HDAC8

Gunning Group at TEDxMississauga

Gunning Group at TEDxMississauga

Gunning Group at TEDxMississauga

Prof. Patrick Gunning is named the recipient of the CSC Bernard Belleau Award

Prof. Patrick Gunning is named the recipient of the CSC Bernard Belleau Award

Prof. Patrick Gunning is named the recipient of the CSC Bernard Belleau Award

Recent Posts

Gunning Group recognized with Connaught Innovation Award!

Dunad Therapeutics has struck a new multi-million dollar deal with Novartis

Gunning Group receives $100,000 grant from Brain Cancer Canada

Patrick Gunning recognized with Connaught Innovation Award

Our PhD graduate Aaron Cabral to pursue career in drug discovery

Murtaza Hassan featured in U of T's Tetris-themed solution to battling Cancer

Congrats Murtaza on Publishing the Tetris-based approach to targeting HDAC8

Our PhD Student, Murtaza Hassan, turns to 80s video game to combat cancer

Scientific Breakthrough

STAT3 a New Research for Duchenne Muscular Dystrophy

Archive

Search By Tags

Follow Us

bottom of page